BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24175783)

  • 1. Opportunistic screening for cervical cancer in a tertiary hospital in Karnataka, India.
    Kulkarni PR; Rani H; Vimalambike MG; Ravishankar S
    Asian Pac J Cancer Prev; 2013; 14(9):5101-5. PubMed ID: 24175783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of specific chromosomal regions assessed by fluorescent in situ hybridization on Pap smears to be added as screening tool for identifying women at risk of progressing to cervical cancer.
    Upendram P; Sahni S; Mohiuddin K; Poornima S; Gourishankar B; Kumar Vattam K; Boddala P; Jayashankar E; Mohiuddin S; Kamineni V; Mohan V; Houldsworth J; Hasan Q
    Tumour Biol; 2017 Oct; 39(10):1010428317698363. PubMed ID: 28990460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
    Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
    J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of abnormal cervical cytology in papanicolaou smears in a tertiary care center.
    Hirachand S; Bajracharya J; Pradhanang S; Lama S
    JNMA J Nepal Med Assoc; 2013; 52(191):462-5. PubMed ID: 24907951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and course of preinvasive cervical lesions during pregnancy in a Northern Nigerian Teaching Hospital.
    Bakari F; Abdul MA; Ahmed SA
    Ann Afr Med; 2017; 16(2):74-80. PubMed ID: 28469121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of various screening techniques in detecting preinvasive lesions of the cervix among symptomatic women and women having unhealthy cervix.
    Nayak PK; Mitra S; Agrawal S; Hussain N; Thakur P; Mishra B
    J Cancer Res Ther; 2021; 17(1):180-185. PubMed ID: 33723152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silent High Grade Cervical Intraepithelial Neoplasia in Atypical Smears from Liquid Based Cervical Cytology - Three Years Experience in Thammasat University Hospital.
    Lertvutivivat S; Chanthasenanont A; Chanthasenanont A; Muangto T; Nanthakomon T; Pongrojpaw D; Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2016; 17(9):4353-4356. PubMed ID: 27797243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of cervical high-grade squamous intraepithelial lesions and squamous cell carcinoma in women with high-risk human papillomavirus and normal cervical cytology: A retrospective analysis of 1858 cases stratified by age and human papillomavirus genotype.
    Gu L; Hong Z; Gao H; Qiu L; Di W
    Cytopathology; 2019 Jul; 30(4):419-425. PubMed ID: 31069857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results.
    Alexander C; White M; Maleki Z; Rodriguez EF
    Acta Cytol; 2019; 63(5):417-423. PubMed ID: 31195388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability of On-Site Evaluation of Cervical Cytology Smears Stained with Toluidine Blue to Reduce Unsatisfactory Results.
    Tummidi S; Shankaralingappa A; Sharmila V
    Acta Cytol; 2022; 66(6):513-523. PubMed ID: 36215977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance of HPV, conventional smear, colposcopy, and conization results in cervical dysplasia.
    Aydogan Kirmizi D; Baser E; Demir Caltekin M; Onat T; Sahin S; Yalvac ES
    Diagn Cytopathol; 2021 Jan; 49(1):132-139. PubMed ID: 33118711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
    Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
    Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of Cervical Cancer Screening in the Rural Population of Lucknow West, India, through a Camp Approach.
    Misra JS; Srivastava AN; Gupta HP
    Acta Cytol; 2018; 62(4):273-278. PubMed ID: 29898440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Risk Assessment of Cervical Cancer Screening by Papanicolaou Smear and Visual Inspection with Acetic Acid for Pregnant Women at a Thai Provincial Hospital.
    Lertcharernrit J; Sananpanichkul P; Suknikhom W; Bhamarapravatana K; Suwannarurk K; Leaungsomnapa Y
    Asian Pac J Cancer Prev; 2016; 17(8):4163-7. PubMed ID: 27644678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic melanoma of the uterine cervix diagnosed on cervical Pap smear: Case report and literature review.
    Shachner TR; Van Meter SE
    Diagn Cytopathol; 2018 Dec; 46(12):1045-1049. PubMed ID: 30354020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital.
    Tao X; Zhang H; Zhang H; Xiao J; Li J; Zhou X; Wang L; Zhao C
    Cancer Cytopathol; 2019 Apr; 127(4):258-266. PubMed ID: 30892831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Study of Pap Smears in HIV-Positive and HIV-Negative Women from a Tertiary Care Center in South India.
    Gupta K; Philipose CS; Rai S; Ramapuram J; Kaur G; Kini H; Gv C; Adiga D
    Acta Cytol; 2019; 63(1):50-55. PubMed ID: 30721904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
    Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV immunisation and cervical screening--confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study.
    Palmer TJ; McFadden M; Pollock KG; Kavanagh K; Cuschieri K; Cruickshank M; Cotton S; Nicoll S; Robertson C
    Br J Cancer; 2016 Mar; 114(5):582-9. PubMed ID: 26931370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
    BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.